ClinicalTrials.gg
Sign In
CompletedNCT03276117labourRecordUpdated Sep 8, 2017

Wide Use of Paperless Partograph in Evaluation of Labour

An observational study in Labor Complication and Labor Pain, sponsored by Assiut University. Completed at 6 sites in Egypt. Open to female participants aged 25 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-09-08.

Sponsored by Assiut University · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
25 Years to 35 Years
Sex
Female
01

Study summary

Paperless partograph wide using in labour room as simple tool in evaluation of labour

Read the detailed description

Both world health organization ( WHO) PARTOGRAPH and modified world heath organization (WHO)PARTOGRAPH are too long labour tools in evaluation of labour so we need simple tool in evaluation of labour

02

Conditions studied

  • Labor Complication
  • Labor Pain

Keywords

  • pregnancy.obstructed labour
03

In context

Obstetric Labor Complications

88 studies on the registry are indexed under Obstetric Labor Complications; 24 are open to participants now.

This study's enrollment of 200 is below the median of 300 across 25 observational studies indexed under Obstetric Labor Complications.

Browse Obstetric Labor Complications studies →

Lead sponsor

Assiut University is the lead sponsor of 5,079 studies on the registry; 2,177 are open to participants now.

Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Browse Assiut University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

the collected data wail be analyzed using the statistical package for social science (version 10.0 for windows,SPSS.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Spontaneous labour
  • cephalic presentation
  • pregnant 37 weeks up to full term

Exclusion criteria

Exclusion Criteria:

  • mail_presentation
  • induced labour
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna
06

What researchers measure

Primary outcomes

  1. Progress of labour

    Cervical dilated 1 cm each hour

    Time frame: up to 2 month

Secondary outcomes

  1. New born

    Apgar scor at 1 minute and Apgar scor at 5 minutes

    Time frame: up to 1 month

07

Study locations

6 sites
  • Faculity of Medicine ,in Assiut,Egypt
    Assiut, 71723, Egypt
  • Faculity of Medicine Assiut University
    Assiut, 71723, Egypt
  • Faculity of Medicine in Assiut,Egypt
    Assiut, 71723, Egypt
  • Faculity of Medicine,in Assiut ,Egypt
    Assiut, 71723, Egypt
  • Faculity of Medicine,in Assiut,Egypt
    Assiut, 71723, Egypt
  • Faculity of Medicine
    Assiut, 71723, Egypt
08

References and documents

Publications

  • Jadad AR, McQuay HJ. Searching the literature. Be systematic in your searching. BMJ. 1993 Jul 3;307(6895):66. doi: 10.1136/bmj.307.6895.66-a. No abstract available. PubMed 8343701 ↗
  • Chang AA, Heskett KM, Davidson TM. Searching the literature using medical subject headings versus text word with PubMed. Laryngoscope. 2006 Feb;116(2):336-40. doi: 10.1097/01.mlg.0000195371.72887.a2. PubMed 16467730 ↗
  • Fatehi F, Gray LC, Wootton R. How to improve your PubMed/MEDLINE searches: 3. advanced searching, MeSH and My NCBI. J Telemed Telecare. 2014 Mar;20(2):102-12. doi: 10.1177/1357633X13519036. PubMed 24614997 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Feb 2017 to primary completion in Aug 2017, 6 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 4, 2017
First posted
Sep 8, 2017
StartActual
Feb 2, 2017
Primary completionActual
Aug 21, 2017
CompletionActual
Aug 26, 2017
Last update
Sep 8, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03276117
Lead sponsor
Assiut University
Responsible party
ayman darder (principal investigator, Assiut University) — Principal investigator
First posted
Sep 8, 2017
Start date
Feb 2, 2017
Primary completion
Aug 21, 2017
Completion
Aug 26, 2017
Last update
Sep 8, 2017

Study contacts

mohamed khalaph, professor
study chair · assiut universty faculity of medicine
ahmad abass, professor
principal investigator · assiut university faclity of meficibe

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Obstetric Labor Complications →

Other studies from this sponsor

Assiut University →

Start the discussion